Megan Sniecinski — SEC Insider Profile, Roles & Companies

Insider at

04

BCRX buying Nov. 18, 2019 PRAX

Insider transactions

05

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 14, 2026	PRAX	A	89	$167.94	$14,947	28,664 Direct	+0.31%	Acquired	50.6% (price as of 2026-10-23)
Jan. 12, 2026	PRAX	F	885	$275.74	$244,030	28,530 Direct	-3.01%	Disposed	-8.3% (price as of 2026-10-23)
Jan. 10, 2026	PRAX	F	1,087	$288.45	$313,545	29,415 Direct	-3.56%	Disposed	-12.3% (price as of 2026-10-23)
Jan. 8, 2026	PRAX	A	9,625	·	·	30,502 Direct	+46.10%	Acquired
Jan. 8, 2026	PRAX	A	7,700	·	·	7,700 Direct	·	Acquired
Dec. 15, 2020	BCRX	A	225,000	·	·	225,000 Direct	·	Acquired
Dec. 17, 2019	BCRX	A	240,000	·	·	240,000 Direct	·	Acquired
Dec. 17, 2019	BCRX	A	202,000	·	·	202,000 Direct	·	Acquired
Nov. 18, 2019	BCRX	P	45,000	$1.45	$65,250	45,000 Direct	·	Acquired	427.6% (price as of 2026-10-23)
July 1, 2019	BCRX	A	500,000	·	·	500,000 Direct	·	Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Jan. 8, 2026	PRAX	Stock Option (Right to Buy)	Common Stock (7,700)	$294.38	Jan. 8, 2036	7,700	Acquired
Dec. 15, 2020	BCRX	Emp. Stock Option (Right to Buy)	Common Stock (225,000)	$8.31	Dec. 15, 2030	225,000	Acquired
Dec. 17, 2019	BCRX	Emp. Stock Option (Right to Buy)	Common Stock (240,000)	$3.23	Dec. 17, 2029	240,000	Acquired
Dec. 17, 2019	BCRX	Emp. Stock Option (Right to Buy)	Common Stock (202,000)	$3.23	Dec. 17, 2029	202,000	Acquired
July 1, 2019	BCRX	Emp. Stock Option (Right to Buy)	Common Stock (500,000)	$3.71	July 1, 2029	500,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Jan. 9, 2026	PRAX	Common Stock	20,877	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (11,999)	11,999	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (821)	821	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (9,999)	9,999	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (30,000)	30,000	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (36,400)	36,400	Direct
Jan. 9, 2026	PRAX	Stock Option (Right to Buy)→ Common Stock (22,500)	22,500	Direct

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BCRX

Chief Business Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2021	$286,192	·	·	$6,952,056	·	·	$690,876	$7,929,124
2020	$456,750	·	·	$1,271,385	$228,375	·	$55,825	$2,012,335
2019	$225,000	·	·	$1,773,364	$153,000	·	$25,590	$2,176,954

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.